Piermont Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-61,620	Closed	-$1.3M	–	256
2018 Q1	$1.3M	Buy	+61,620	New	+$1.3M	0.43%	106